Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.84 USD | +2.55% | -0.50% | +125.86% |
05-07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
05-06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+125.86% | 602M | |
+29.90% | 48.16B | |
-0.95% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.46% | 25.59B | |
-22.93% | 18.96B | |
+8.26% | 12.92B | |
+28.92% | 12.03B | |
-2.14% | 11.77B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Transcript : Stoke Therapeutics, Inc. - Shareholder/Analyst Call